INTRODUCTION
Sepsis is defined as a systemic inflammatory response to infection [1] . Approximately half of the patients with development of single or multiple organ failure (OF). The pathogenic mechanism of OF is considered to involve the systemic release of pro-inflammatory cytokines, such as tumour necrosis factor-α and interleukin-1β (IL-1β), which stimulate the vascular endothelium (reviewed in [3, 4] ). An activated endothelium promotes neutrophil and monocyte tissue sequestration in a stepwise manner. Phagocyte tethering to and subsequent rolling on endothelial cells is mediated by the selectins, a family of cell adhesion molecules. The subsequent firm adhesion and transmigration of phagocytes into tissues are dependent on multiple adhesion molecules, including the β2-integrin CD11b\CD18 [5] . Upon activation, the sequestered phagocytes release enzymes and activated oxygen species, which result in microvascular and tissue injury, leading ultimately to OF [6] .
The results of studies on sepsis have shown that therapies using specific cytokine inhibitors fail to reduce mortality [7, 8] . However, in these trials with hundreds of patients, the inclusion criteria were built up mainly on the basis of the clinical criteria of systemic inflammatory response syndrome (SIRS) [1] , which are broad and also cover patients with mild disease. Furthermore, the microbiological findings were variable, and little, if any, attention was paid to the presence of positive blood culture. Such selection criteria inevitably render the treatment groups extremely heterogeneous in terms of severity and quality of the ongoing systemic inflammatory response [9] and the risk of the development of OF and death. Evidently, OF-predicting markers in patients with sepsis are needed. The death of patients with septic shock is, in the majority of cases, caused by the multiple OF which commonly occurs in weeks 2-3 of the illness. The purpose of the present study was to define predictors of OF in strictly defined patient groups, i.e. in patients with sepsis and septic shock who : (i) had a positive blood culture, (ii) met the criteria of SIRS [1] , and (iii) lived for 7 days or more after sampling for the blood culture.
We focused on abnormalities in the following markers measured from serial blood samples : (i) cell surface expression of CD11b on peripheral blood neutrophils and monocytes, which increases upon phagocyte activation [10] ; (ii) circulating levels of IL-6 and IL-8, which appear to be related to the severity of sepsis [11, 12] , soluble E-selectin (sE-selectin), an activation marker of the vascular endothelium [13, 14] , soluble IL-2 receptor (sIL-2R), a marker of lymphocyte activation [15] , and C-reactive protein (CRP), an acute-phase protein ; and (iii) routine haematological laboratory tests. We evaluated the presence of OF at day 7 after taking the blood culture using the criteria of Knaus et al. [16] , and compared the patients with OF (OF group) with patients without OF (NOF group). We also calculated a sepsisrelated inflammation severity score (SISS) on the basis of the markers found at the time of the first blood sample (T1) to be related to the subsequent development of OF. Finally, we used these SISS values to characterize the immunoinflammatory response profile of individual patients at T1.
METHODS

Patients
The study was carried out during a 9-month period at the Helsinki University Central Hospital, Helsinki, Finland. It was approved by the institutional review board. All subjects or their next of kin gave informed consent for participation. Patients with haematological malignancies were excluded from the study. The criteria for SIRS, sepsis and septic shock were as defined by the consensus committee of ACCP and SCCM [1] . As soon as the laboratory notified the ward or intensive care unit personnel about a positive blood culture test, the medical records of the patient were checked if the patient met at least two of the SIRS criteria at the time of sampling for blood culture. Then informed consent was obtained, and the first blood sample was collected. This sampling time (T1) was maximally 48 h after sampling for the blood culture. Follow-up samples were collected 2 days (T2) and 4 days (T3) after T1. A total of 27 consecutive patients with a positive blood culture and SIRS were recruited. Two shock patients died at days 4 and 6 Glasgow Coma Score 6 in absence of sedation respectively, and five patients that were normotensive on admission were discharged from the hospital before the end of the follow-up period, and were therefore excluded from the study. Thus the study group comprised 20 patients. Nine of the patients presented in shock and were primarily admitted to the intensive care unit. The presence of OF in the shock patients was assessed as described by Knaus et al. [16] (Table 1 ) on day 7 after sampling for the blood culture. Six patients with OF were sedated ; consequently, neurological scoring was not performed. In addition to the definitions of Knaus et al. [16] , we used an auxiliary criterion for cardiovascular failure [17] , i.e. the need for adrenergic support for at least 1 h with doses as follows : dopamine, 15 µg:kg −" :min −" , adrenaline, 0.1 µg:kg −" :min −" ; or noradrenaline, 0.1 µg:kg −" :min −" . We evaluated the general clinical condition of the shock patients using the Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring system [18] within 24 h of admission to the intensive care unit (the highest score), and described organ dysfunction in the shock patients at T1, T2 and T3 using the sepsis-related organ failure assessment (SOFA) score [17] , with the exception of the score on the Glasgow Coma Scale, which was not included if the patient was sedated. Healthy subjects to act as controls (n l 56) were recruited from hospital staff who were not taking medication and had no clinical infection.
Blood samples
Blood samples were drawn from each patient at T1, T2 and T3. Immediately after sampling, comparable samples were drawn from a healthy volunteer. Sampling was by venipuncture, or by aspiration from an arterial catheter using a pyrogen-free syringe (B. Braun, Melsungen AG, Melsungen, Germany). One sample was collected into a prechilled polystyrene tube (Falcon no. 2058 ; BectonDickinson Labware, Lincoln Park, NJ, U.S.A.) supplemented with 500 µl of pyrogen-free citrate (113 mmol\l; Baxter Healthcare Ltd., Thetford, Norfolk, U.K.) and 300 µl of dextran (M r 70 000 ; 60 g in 1000 ml of 0.9 % NaCl ; Kabi Pharmacia, Uppsala, Sweden). A second sample was drawn into an EDTA tube (Venoject VT-053TKZ ; Terumo Europe N. V., Leuven, Belgium ; 0.06 ml of EDTA for 3 ml of blood), and a third into a serum collection tube (Venoject ; Terumo Europe N. V.). Furthermore, additional samples were drawn from each patient for determining routine blood cell counts and the serum concentration of CRP. Samples obtained on a given day from the patient(s) and a control subject were processed in parallel. The tubes containing citrateanticoagulated samples were incubated for 60 min on ice at 0 mC, and then the leucocyte-rich plasma layers were collected into prechilled empty tubes, which were retained on ice until the labelling of cells with monoclonal antibodies (see below). Serum and EDTA plasma were obtained by centrifugation (1000 g, 10 min, 4 mC), and stored in aliquots at k20 mC until use.
Flow cytometry
The cell labelling for flow cytometry was as described previously [10, 19] . Briefly, aliquots of the buffy-coat cell suspension were double-labelled by the addition of pretitrated amounts of fluorescein-isothiocyanate-conjugated CD14 (mouse anti-CD14 IgG2b) and phycoerythrin-conjugated CD11b (mouse anti-CD11b IgG2a) or a corresponding control [phycoerythrin-conjugated mouse anti-(keyhole limpet haemocyanin) IgG2a] antibody (Becton Dickinson, San Jose, CA, U.S.A.). Contaminating erythrocytes were lysed by the addition of 1 : 10-diluted ice-cold FACS lysing solution (Becton Dickinson). The leucocytes were collected by centrifugation (350 g, 5 min, 4 mC), washed once in ice-cold PBS, and resuspended in 300 µl of ice-cold PBS containing 0.5 % formaldehyde. Finally, the cells were stained with LDS-751 (Exciton, Dayton, OH, U.S.A.), a nucleic acid dye.
A FACScan flow cytometer (Becton Dickinson) and LYSYS II software were used for the acquisition and analysis of the data. Two separate data sets, one for neutrophils (5i10$ LDS-751-positive events) and the other for monocytes (10$ CD14-positive events), were acquired for each specimen, as described previously [10, 19] . First, in a forward\side light-scatter dot-plot, LDS-751-positive neutrophils were separated from contaminating mononuclear cells by creating a region R1. Secondly, in an LDS-751 fluorescence\side scatter dotplot, a second region, R2, was created to separate neutrophils from damaged cells, which show a strong LDS-751 fluorescence signal due to markedly increased permeability. Finally, CD11b expression on neutrophils (i.e. on cells co-located in regions R1 and R2) was evaluated by creating a CD11b histogram. CD14-positive monocytes were analysed similarly. CD11b expression is presented in relative fluorescence units (RFU), i.e. as the median channel of the positively fluorescent cell population.
Plasma concentrations of IL-6 and sE-selectin, serum concentrations of sIL-2R, IL-8 and CRP, and cell counts
ELISA kits for determing IL-6 (Predicta ; Genzyme Corp., Cambridge, MA, U.S.A.) and sE-selectin (Bender MedSystems, Vienna, Austria) had detection limits of 35 pg\ml and 1.6 ng\ml respectively. Serum samples for measurement of sIL-2R and IL-8 (detection limit of 5 pg\ml) were analysed by a chemiluminescent immunoassay system (Immulite ; Diagnostic Products Corp., Los Angeles, CA, U.S.A.). The reagents for the immuno-turbidimetric measurement of the serum CRP concentration were purchased from Orion Diagnostica (Espoo, Finland). The detection limit was 2 µg\ml. Cell counts were determined using an automatic analyser.
SISS values
To evaluate immunoinflammatory marker profiles at T1 in relation to the development of OF, we first selected the markers that could be correlated with the development of OF (see the Results section). Taking into account the results of previous studies, we then defined arbitrarily the cut-off limits of ' high response ' for each marker as follows : IL-6, 500 pg\ml [20] ; IL-8, 200 pg\ml [12] ; sIL-2R, 4000 units\ml [21] ; phagocyte CD11b expression level 200 RFU (on either monocytes or neutrophils) ; platelet count, 50i10*\litre [17] ; monocyte count, 0.05i10*\litre. A value of 1.0 was assigned if the level of a given marker reached the ' high response ' category, and a value of 0 was assigned if it did not. In addition, the presence of shock yielded a high response value of 1. Finally, the scores were summed to generate a SISS value for each patient. The maximum SISS value was 7 (i.e. IL-6 500 pg\ml ; IL-8 200 pg\ml ; sIL-2R 4000 units\ml ; CD11b expression level 200 RFU ; platelet count 50i10*\litre ; monocyte count 0.05i10*\litre ; and the presence of shock).
Data analysis
Results are given as median values, with ranges. Statistical comparisons between the groups were carried out using Kruskal-Wallis analysis of variance or the MannWhitney U test, as appropriate. To examine correlations between two parameters, Spearman's rank correlation was used. Differences were regarded as statistically significant when P 0.05. Area under the curve (AUC) values for the serial measurements of monocyte counts (10*\lidays), platelets (10*\lidays), CD11b expression on neutrophils and monocytes (RFUidays), and IL-6 (pg\mlidays), IL-8 (pg\mlidays), sE-selectin (ng\mlidays), sIL-2R (units\mlidays) and CRP (µg\mlidays) concentrations were calculated from T1 to T3 by the trapezoidal rule. The data were analysed using the statistical program Systat for Windows, version 5.0 (Systat, Evanston, IL, U.S.A.).
RESULTS
Patients
The characteristics of the patients (twelve men and eight women) are shown in Table 2 . Blood cultures from ten patients grew Gram-positive bacteria, and those from the ten other patients grew Gram-negative bacteria. Eleven patients presented with normotensive sepsis, which was community-acquired in nine patients and hospitalacquired in two patients (nos. 10 and 18 ; Table 2 ). These patients were treated in the medical (nine patients), neurological (one patient) and surgical (one patient) wards, and recovered without complications. Nine other patients had community-acquired sepsis, presented in shock and were treated in the intensive care unit. Eight of these had OF on day 7 after taking blood for culture (Table 3) . Consequently, the NOF group comprised 12 patients (11 normotensive patients and one patient with shock), and the OF group comprised eight patients with shock. Out of three patients with meningococcal infection, two patients (nos. 4 and 8) developed OF, whereas the other (patient no. 9) did not ; their APACHE II score values within 24 h of admission were 15, 20 and 21 respectively (Table 3) . OF patients were on average younger (median 44 years ; range 23-63 years) than NOF patients (59 years ; 17-86 years), but this difference was not statistically significant. The median length of stay in hospital was 20 days for the OF group (range 11-60 days) and 14 days for the NOF group (8-48 days). Three OF patients died of multiple organ dysfunction 11-29 days after hospitalization, and one NOF patient died of mesothelioma of the peritoneum on day 37.
Haematological findings
The major haematological findings at T1, i.e. within 48 h after sampling for blood culture, and at T2 and T3 (2 and 4 days after T1 respectively) are presented in Table 4 . At T1, the platelet count of the OF group was significantly lower than that of the NOF group. Also, the median AUC value for the platelet counts differed significantly between the OF and NOF groups [251 (range 128-618) and 689 (246-1190) respectively ; P l 0.001]. At T1, but not at T2 or T3, OF patients had significantly lower monocyte counts, whereas the corresponding differences in neutrophil and lymphocyte counts were not significant. Figure 1 shows that OF patients, compared with NOF patients, exhibited at T1 significantly higher median CD11b expression on neutrophils [148 RFU (range 74-269 RFU) and 86 RFU (44-143 RFU) respectively ; P 0.01] and on monocytes [221 RFU (66-328 RFU) and 76 RFU (27-202 RFU) respectively ; P l 0.01]. During follow-up, the CD11b expression levels decreased in both patient groups, but persisted at a higher level in OF patients. In accordance with this, the OF group had higher median AUC values for neutrophil and monocyte CD11b expression than did the NOF group [for neutrophils, 430 (range 284-598) and 292 (180-417) respectively (P 0.01) ; for monocytes, 554 (227-1546) Predicting organ failure in septic shock *Laparotomy due to intestinal occlusion 7 days before onset of fever and sampling for blood culture. †Operated on due to fractures of pelvis, spine, humerus and calcaneus 15 days before onset of fever and sampling for blood culture.
CD11b expression
Table 3 Severity of illness of patients with septic shock
Values are shown for patients 1-9 as listed in Table 2 . APACHE II scores were obtained within 24 h of admission. OF was defined according to Knaus et al. [16] (see Table 1 ). ICU-LOS, length of stay in intensive care unit. and 253 (141-427) respectively (P 0.01)]. There was a statistically significant positive correlation for CD11b expression between neutrophils and monocytes at T1 (r l 0.763 ; P 0.001).
IL-6 and IL-8
At T1, each OF patient and five out of 11 NOF patients had elevated IL-6 levels (Figure 2A ), and the difference between the OF group and the NOF group was significant [595 pg\ml (range 125-20 800 pg\ml) and 0 pg\ml (0-900 pg\ml) respectively ; P l 0.001] ( Figure  2 ). During the follow-up, IL-6 concentrations of OF patients had decreased at T2, and thereafter remained at a steady-state elevated level. The OF group also had a higher AUC value for IL-6 concentration than did the 
CRP levels
At T1, serum CRP concentrations were markedly elevated and almost identical in the two patient groups [OF group, 193 µg\ml (range 69-441 µg\ml) ; NOF group, 196 µg\ml (49-295 µg\ml)] ( Figure 2C ). During the follow-up, the CRP level persisted at a high and virtually unaltered level in the OF group, but decreased steeply in the NOF group. Accordingly, the OF group had a higher AUC value for CRP concentration [622 (range 486-1117), compared with 475 (110-699) ; P 0.05].
sE-selectin
Figure 3(A) shows that the plasma sE-selectin concentrations at T1 did not differ in a statistically significant fashion between the OF and NOF groups [243 ng\ml (range 89-713 ng\ml) and 154 ng\ml (61-394 ng\ml) respectively]. In the the follow-up period the sE-selectin levels remained raised in both groups, and thus the AUC Predicting organ failure in septic shock
Figure 2 Concentrations of IL-6 (A), IL-8 (B) and CRP (C)
See the legend to Figure 1 for details of groups at T1, T2 and T3. OF group, n l 8 ; NOF group, n l 11-12 ; controls (C) for IL-6 and IL-8, n l 20. Broken lines indicate detection limits of the assays for IL-6 (35 pg/ml) and IL-8 (5 pg/ml), and horizontal bars denote median values. Significance of differences : IL-6, OF versus C, P 0.001 at each time point ; IL-8, OF versus C, P 0.001 at each time point ; NOF versus C, P l 0.001 at T1 and P 0.05 at T2. Median values below detection limits are not shown.
values were much the same [OF group, 617 (range 311-1314) ; NOF group, 533 (207-853)].
sIL-2R
At T1, the serum sIL-2R level of the OF group (3815 units\ml ; range 2051-27 120 units\ml) was higher than that of NOF group (1513 units\ml ; range 773-11 274 units\ml ; P 0.05) ( Figure 3B ). The median serum levels of both patient groups differed significantly at all time points from the respectives value of healthy subjects (404 units\ml ; range 285-654 units\ml ; all P 0.001). In addition, the AUC value for sIL-2R of the OF group was higher than that of the NOF group [13 411.5 (range 6506-63 218), compared with 5409 (2734-25 183) ; P 0.01].
Figure 3 Concentrations of sE-selectin (A) and sIL-2R (B)
See the legend to Figure 1 for details of groups at T1, T2 and T3. OF group, n l 8 ; NOF group, n l 11-12, controls (C), n l 20-25. Horizontal bars denote median values. The OF group and the NOF group both differed significantly from controls at each time point (all P 0.001).
Profiles of markers in relation to the development of OF
In order to evaluate immunoinflammatory marker profiles at T1 in relation to the development of OF, we used SISS values calculated on the basis of markers that were related to the development of OF and the presence of shock (see the Methods section). The maximum SISS value was 7. The results in Table 5 show that each of the eight shock patients who subsequently developed OF had a SISS value of 2. One patient with shock who recovered without OF had a SISS value of 1 (patient 9). In the NOF group, three patients had a SISS value equal to 1 (patients 10, 13 and 16), and eight patients had values of 0 (results not shown).
Severity of illness in relation to organ dysfunction
Among the nine patients with shock, the SOFA score at T3 was correlated with the APACHE II score within 24 h of admission ( Figure 4A ), but not with CD11b expression levels, IL-6, IL-8 or sIL-2R concentrations, or counts of monocytes or platelets determined at T1 (results not shown). Next, we correlated the APACHE II score on admission with the T1 markers listed above. There was a negative correlation between CD11b expression on monocytes and APACHE II score ( Figure  4B ), whereas the other correlations were not significant. 
DISCUSSION
Our results show that, by using SISS values based on humoral and cellular markers of systemic inflammation and on the presence of shock, it is possible to identify patients who subsequently develop OF. Nine of the 20 patients studied presented with rapid onset of shock triggered by community-acquired infection, and eight of these developed OF. Five OF patients had high concentrations of IL-6 and\or IL-8 (patients 1, 4, 7 and 8 ; Table  5 ), a cytokine profile strikingly similar to that described by Damas et al. [22] in their patients with rapid onset of shock. In the other three patients in the present study the cytokine levels were not markedly elevated, but one had a low platelet count and a greatly elevated sIL-2R level (patient 2), and two were characterized by cell-associated abnormalities only : one by the absence of monocytes (patient 5) and the other by greatly increased CD11b expression (patient 6). Single abnormalities also occurred in the NOF group (patients 10, 13 and 16 ; Table 5 ), indicating that a markedly abnormal value as an isolated finding in the absence of shock is not predictive of OF. The range of IL-6 concentrations is wide in septic shock [23] , and a high IL-6 level as a single marker lacks both specificity and sensitivity in identifying patients who might benefit from immunotherapy [7] . The results suggest that, when predicting OF at the level of a patient, it is crucial to take into account both the presence of shock and the profile of multiple markers of inflammation.
Of the three patients with meningococcal septic shock and high APACHE II score values indicating severe disease, two (patients 4 and 8 ; Table 5 ) had a cytokine profile compatible with that in rapid onset of shock and both developed OF, whereas the third had only minor changes in the inflammation markers and did not develop OF. This variation in severity of inflammation can derive, at least partly, from genetic factors [24] . The findings suggest that it is possible to identify, for the first time, septic shock patients who may not develop OF.
Phagocyte CD11b expression is increased in sepsis [10, 25, 26] . Increased expression is associated with the development of organ dysfunction in selected patients [27] . We observed that CD11b expression levels were higher in patients with subsequent OF than in patients without OF. Lin et al. [25] , however, did not find such a difference between patients with sepsis and septic shock, or between sublethal and lethal sepsis in a rat model [28] . The discrepancy may derive from differences in clinical end-points used, CD11b determination methodology, or other factors.
The count of CD14-positive monocytes is depressed in septic shock [25, 29] . We found that monocyte counts were lower in patients with subsequent OF than in NOF patients. In animal models, activated monocytes are sequestrated within tissues [30] . In the present study, monocyte CD11b expression levels were higher in the OF group than in the NOF group, suggesting that the monocytes of the former were more highly activated. Among the OF patients, monocyte CD11b expression was negatively correlated with APACHE II score. Although this finding must be interpreted cautiously, it may indicate that highly CD11b-positive monocytes are sequestrated in relation to the severity of the disease.
High levels of sE-selectin [13] and sIL-2R [31] occur in sepsis. In our patients, both sE-selectin and sIL-2R levels were significantly elevated as compared with those in healthy adults. However, the sE-selectin levels of the OF and NOF groups were comparable. This, and previous findings [32] , suggest that high sE-selectin levels are not predictive of OF. sIL-2R levels, in contrast, were significantly higher in the OF group than in the NOF group, and hence were predictive of OF. Low platelet counts, caused by consumption, haemophagocytosis [33] or both, are related to mortality in sepsis [34] . We also found lower platelet counts in the OF group than in the NOF group. Finally, CRP serves as an indicator of resolution of sepsis [35] . Our results confirm this, and also show that a high CRP level is not predictive of OF.
In conclusion, our results show that, in sepsis defined by a positive blood culture, increased phagocyte CD11b expression, low platelet and monocyte counts, and high levels of IL-6, IL-8 and sIL-2R, but not of CRP and sEselectin, are predictive of OF. The markers may help to select patients for studies of immunotherapy in septic shock due to community-acquired infection.
